Exchange: NASDAQ·Updated 05:09 PM EDT
KZR logo

KZR Kezar Life Sciences Inc

$7.29
$0.07
(0.95%)
Today
Closed $7.29
$0.08
(1.10%)
After Hours
Reported EarningsNov 12
Mkt Cap$53.86M
Vol616,015.00

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 19, 2015 and is headquartered in South San Francisco, CA.
48

Neutral Sentiment

How do you feel about KZR?

Advertisement|Remove ads.